Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06599476 · ClinicalTrials.gov registry record · NA
Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy
A NA study of Prostate Cancer, sponsored by Advanced Radiation Centers of New York.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06599476: Active NA study of Prostate Cancer, sponsored by Advanced Radiation Centers of New York.
NCT06599476 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Advanced Radiation Centers of New York. The registered enrollment target is 150 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06599476, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Advanced Radiation Centers of New York.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective clinical study involving up to 150 subjects with localized prostate cancer who are scheduled for radiation treatment with rectal spacer placement. The goal of this clinical trial is to assess the safety and efficacy of perirectal spacers in patients undergoing radiation therapy for the treatment of localized prostate cancer. Study visits: * Screening * Spacer placement * Treatment planning simulation * End of the radiation treatment * 1,3,and 6-months FU visits.
Primary Outcome
Dose-volume histogram (DVH) including the percent of the rectal volume receiving 70 Gy
Conditions Studied
Interventions
- DEVICE BioProtect Balloon Implant™ System
Study Locations (1)
New York
- Advanced Radiation Centers of New York - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-05-21 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT06599476 still lists
NCT06599476 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which BioProtect Balloon Implant™ System is the first listed.
NCT06599476 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06599476 about?
NCT06599476 is a clinical study titled "Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy". This is a prospective clinical study involving up to 150 subjects with localized prostate cancer who are scheduled for radiation treatment with rectal spacer placement. The goal of this clinical trial is to assess the safety and efficacy of perirectal spacers in patients undergoing radiation therap...
What is the current status of trial NCT06599476?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-05-21. Estimated completion is 2025-12.
What conditions does trial NCT06599476 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT06599476?
The interventions under investigation include: BioProtect Balloon Implant™ System (DEVICE).
Who is sponsoring clinical trial NCT06599476?
This trial is sponsored by Advanced Radiation Centers of New York, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06599476 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06599476's enrollment target sits among peer trials
150 260th of 735 higher than 464 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02455479 · 150 participants · Phase 1
Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI